Formulation of Nanovaccines toward an Extended Immunity against Nicotine.

ACS Applied Materials & Interfaces
Yun HuChenming Zhang

Abstract

Nicotine vaccines have been investigated to assist with smoking cessation. Because smoking cessation is a long process, past nicotine vaccines required multiple injections to achieve long-term efficacy. It would be of great significance if extended efficacy can be achieved with fewer injections. Here, we report the assembly of lipid-polylactic acid (PLA) and lipid-poly(lactic-co-glycolic acid) (PLGA) hybrid nanoparticle (NP) based nicotine vaccines. Mice immunized with the lipid-PLGA vaccine produced higher titers of nicotine-specific antibodies than the lipid-PLA vaccine in short-term. However, the lipid-PLA vaccine was found to induce long-lasting antibodies. Three months after the immunization, only mice that received first two injections of the lipid-PLGA vaccine and a third injection of the lipid-PLA vaccine achieved a significantly lower brain nicotine concentration of 65.13 ± 20.59 ng/mg than 115.88 ± 37.62 ng/mg from the negative controls. The results indicate that not only the stability of the vaccines but also the combination of the vaccines impacted the long-term efficacy of the immunization. Lastly, both the body weight and the histopathology study suggest that the vaccines were safe to mice. These findings suggest ...Continue Reading

References

Jun 1, 1996·Current Opinion in Immunology·A Lanzavecchia
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Mar 23, 2001·Nature Immunology·M Moser, K M Murphy
Mar 22, 2002·Nature Reviews. Immunology·C B Wilson, E K Marcuse
Sep 25, 2002·Life Sciences·David H MalinAli Fattom
Dec 14, 2002·Science·Nadia L BernasconiAntonio Lanzavecchia
May 8, 2004·Seminars in Immunology·Shane Crotty, Rafi Ahmed
Aug 6, 2005·Vaccine·Risini D WeeratnaHeather L Davis
Sep 18, 2007·Molecular Biotechnology·Joanne L BallardNigel R Swanson
Feb 29, 2008·The Journal of Pharmacology and Experimental Therapeutics·Samuel A RoikoPaul R Pentel
Jul 26, 2008·Nature Nanotechnology·Marina A Dobrovolskaia, Scott E McNeil
Jul 29, 2008·International Immunopharmacology·D E KeylerP R Pentel
Aug 24, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alice O KamphorstMichel C Nussenzweig
Oct 30, 2010·Immunity·Federica SallustoRafi Ahmed
Jan 25, 2011·Trends in Pharmacological Sciences·Riccardo Polosa, Neal L Benowitz
Feb 2, 2011·F1000 Biology Reports·Naomi E Harwood, Facundo D Batista
Feb 22, 2011·American Journal of Preventive Medicine·Sandra J JapuntichTimothy B Baker
Dec 2, 2011·Clinical Pharmacology and Therapeutics·X Y ShenT R Kosten
Feb 24, 2012·Drugs·Tobias RaupachConstant P Onno van Schayck
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Jamie Hartmann-BoyceJacques Cornuz
Nov 13, 2012·International Journal of Nanomedicine·Eleonore Fröhlich
Mar 9, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Serena TonstadKarl-Olov Fagerström
Mar 19, 2013·Expert Review of Vaccines·Raafat E F FahimMatthew W Kalnik
Apr 26, 2013·Vaccine·Michel ZaffranHeidi Lasher
May 31, 2013·Frontiers in Immunology·Sunita AwateGeorge Mutwiri
Oct 5, 2013·Human Vaccines & Immunotherapeutics·Yun HuChenming Zhang
Feb 4, 2014·Advances in Pharmacology·Paul R Pentel, Mark G LeSage
Nov 5, 2014·Frontiers in Immunology·Gestur VidarssonTheo Rispens
Dec 11, 2014·Journal of Medicinal Chemistry·Jonathan W LocknerKim D Janda
Jan 8, 2015·Therapeutic Delivery·Deepak N KapoorSanju Dhawan
Apr 12, 2015·Current Opinion in Biotechnology·Josiah D SmithBret D Ulery
Oct 6, 2015·Trends in Pharmacological Sciences·Phil Skolnick
Oct 9, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nikolai Petrovsky
Mar 2, 2016·The Journal of Clinical Investigation·Tyson J MoyerDarrell J Irvine
May 11, 2016·ACS Nano·Sukru Gokhan ElciRichard W Vachet
Jul 19, 2016·Advanced Drug Delivery Reviews·Betty TylerHenry Brem
Aug 16, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Zongmin ZhaoChenming Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.